CHD

110.8401.06%
JS

Janet S. Vergis

Independent Director

Ms. Janet S. Vergis served as an Independent Director of Teva Pharmaceutical Industries Limited since June 09, 2020 until May 28, 2026. Ms. Vergis serves as Independent Director at SGS SA since March 23, 2021. Ms. Vergis has been Independent Director of DENTSPLY SIRONA Inc. since September 2019. Ms. Vergis served as Executive Advisor of Water Street Healthcare Partners and Deerfield Management Company, L.P. Series C from January 2013 to December 2019. She has been an Independent Director of Church & Dwight Co. Inc. since May 2014. She served as Independent Director of Amneal Pharmaceuticals, Inc. since May 4, 2018 until August 5, 2019. Ms. Vergis identifies and evaluates healthcare investment opportunities at Water Street Healthcare Partners and Deerfield Management Company, L.P. Series C. Ms. Vergis was an Executive-in-Residence at Warburg Pincus LLC since January 2013. Ms. Vergis supported Warburg Pincus in the identification and evaluation of investment opportunities in the biopharmaceutical sector, particularly in the United States. From January 2011 to August 2012, she served as the Chief Executive Officer of OraPharma, Inc., where she led the successful turnaround and subsequent sale of it to Valeant Pharmaceuticals. From 1988 to 2009, she served in various positions of increasing responsibility in executive leadership, research and development, new product development, sales and marketing with Johnson & Johnson and its subsidiaries. She also contributed to a number of Johnson & Johnson companies during her career, serving as a member of company management boards. From 2004 to 2009, she served as the President of Janssen, L.P., Janssen Pharmaceutica NV/Janssen Pharmaceuticals and Johnson & Johnson Consumer Inc. (alternative name McNEIL-PPC Inc.). She was a Director of Impax Laboratories Inc. since October 07, 2015 until May 4, 2018. She served as a Director of Lumara Health, Inc. from November 5, 2013 to 2014 and OraPharma from 2011 to 2012. She was also a member of the board of director MedDay Pharmaceuticals from 2016 to 2021. Ms. Vergis earned an M.S. degree in Physiology and a B.S. degree in Biology from The Pennsylvania State University.

Positions